Trium Capital discloses 10.55% stake in Mural Oncology
PositiveFinancial Markets

Trium Capital has announced a 10.55% stake in Mural Oncology, signaling confidence in the company's potential.
Editor’s Note: This investment highlights Trium Capital's belief in Mural Oncology's innovative approach to cancer treatment, which could lead to significant advancements in the field.
— Curated by the World Pulse Now AI Editorial System